NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/07/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.31 mln
Float0.67 mln
Earnings Date08/13/2026
EPS
1,180
Exceptional
P / E
0.01
Anomalous
Piotroski F-Score
3
/ 9
Below average
Relative Strength
79
/ 100
Strongly outperforming
Debt / Equity
0.06
Debt-free
ROE
-503
Deeply negative
Business Description
Ernexa Therapeutics Inc. is a Cambridge, Massachusetts-based company founded in 2018 that creates stem cell-based treatments for cancer and autoimmune conditions. Its two lead programs use specially engineered stem cells to either attack tumors in ovarian cancer or calm harmful immune responses in rheumatoid arthritis. The company, formerly known as Eterna Therapeutics Inc., operates under a licensing agreement with Factor Bioscience Limited and changed its name in March 2025.
